Pharmaceutical jobs provider Abbott has expressed confidence that its merger and acquisition activity in the last year will help the company to achieve sustained growth in the coming years.
The company has been voted by readers of business publication The Deal as being one of the Most Admired Corporate Dealmakers of 2010, the third consecutive year it has made this list.
Miles White, chairman and chief executive officer of Abbott, described this as an honour and stated that merger and acquisition deals are a key part of its business plan.
Among its 2010 achievements is the takeover of Solvay Pharmaceuticals and Facet Biotech, as well as the agreement of partnerships with Zydus Cadila, Neurocrine and Pierre Fabre.
It also recently completed a deal to purchase Piramal Healthcare Solutions, becoming the largest pharmaceutical company in India in the process, with a local workforce exceeding 10,000 staff.
Mr White said these agreements will help Abbott "establish a leading presence in emerging markets, enhance its pharmaceutical pipeline and capitalise on global growth opportunities to drive continued top-tier performance".